The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In appropriately selected patients, the procedure is associated with an improvement in NYHA class, five year survival free from cardiovascular events of 98.6%, and 10 year survival free from cardiovascular events of 92.3%.67”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Flagged first, then by citations
Research works printed but not linked: 27
- Semsarian, 2015, New perspectives on the prevalence of hypertrophic cardiomyopathy, J Am Coll Cardiol, 65, 1249, 10.1016/j.jacc.2015.01.019 · DOI
- Heric, 1995, Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results, J Thorac Cardiovasc Surg, 110, 195, 10.1016/S0022-5223(05)80026-1 · DOI
- Nishimura, 2017, Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation, Circ Res, 121, 771, 10.1161/CIRCRESAHA.116.309348 · DOI
- Sigwart, 1995, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet, 346, 211, 10.1016/S0140-6736(95)91267-3 · DOI
- Seggewiss, 1998, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients, J Am Coll Cardiol, 31, 252, 10.1016/S0735-1097(97)00508-1 · DOI
- Gietzen, 1999, Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy, Eur Heart J, 20, 1342, 10.1053/euhj.1999.1520 · DOI
- Faber, 1998, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography, Circulation, 98, 2415, 10.1161/01.CIR.98.22.2415 · DOI
- Seggewiss, 2007, Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 96, 856, 10.1007/s00392-007-0579-8 · DOI
- Goodwin, 1995, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet, 346, 1624, 10.1016/S0140-6736(95)91954-6 · DOI
- Geske, 2014, Myectomy versus alcohol septal ablation: experience remains key, J Am Coll Cardiol Intv, 7, 1235, 10.1016/j.jcin.2014.05.022 · DOI
- Pfeiffer, 2012, [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent], Dtsch Med Wochenschr, 137, 2093
- Koljaja-Batzner, 2018, Septal collateralization to right coronary artery in alcohol septal ablation. solution to a dangerous pitfall, J Am Coll Cardiol Intv, 11, 2009, 10.1016/j.jcin.2018.05.034 · DOI
- Elliott, 2014, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, 35, 2733, 10.1093/eurheartj/ehu284 · DOI · Paper page
- Maron, 2003, Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, 348, 295, 10.1056/NEJMoa021332 · DOI · Paper page
- Maron, 2006, Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, 2232, 10.1161/CIRCULATIONAHA.106.644682 · DOI
- Sigwart, 1982, Improvement of left ventricular function after percutaneous transluminal coronary angioplasty, Am J Cardiol, 49, 651, 10.1016/0002-9149(82)91942-7 · DOI
- Brugada, 1989, Transcoronary chemical ablation of ventricular tachycardia, Circulation, 79, 475, 10.1161/01.CIR.79.3.475 · DOI
- Gleichmann, 1996, [Catheter treatment of hypertrophic obstructive cardiomyopathy], Dtsch Med Wochenschr, 121, 679, 10.1055/s-2008-1043055 · DOI
- Veselka, 2016, Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry, Eur Heart J, 37, 1517, 10.1093/eurheartj/ehv693 · DOI · Paper page
- Alam, 2006, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies, J Interv Cardiol, 19, 319, 10.1111/j.1540-8183.2006.00153.x · DOI
- Sorajja, 2013, Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 81, E58
- Singh, 2001, Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy, Mayo Clin Proc, 76, 799, 10.1016/S0025-6196(11)63224-2 · DOI
- Nagueh, 2011, Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, J Am Coll Cardiol, 58, 2322, 10.1016/j.jacc.2011.06.073 · DOI
- Jensen, 2013, Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile, Heart, 99, 1012, 10.1136/heartjnl-2012-303339 · DOI
- Rigopoulos, 2016, Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 105, 953, 10.1007/s00392-016-1005-x · DOI
- Liebregts, 2017, Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol Intv, 10, 1134, 10.1016/j.jcin.2017.03.030 · DOI
- Singh, 2016, A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 88, 107
Cited by
Sorted by citations
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000938 · Cited by 336
Current management of hypertrophic cardiomyopathy
Sikand, N., Stendahl, J., Sen, S., Lampert, R., & Day, S. (2025) · BMJ · doi:10.1136/bmj-2023-077274 · Cited by 26
Metadata
- Authors
- Batzner, A., Pfeiffer, B., Neugebauer, A., Aicha, D., Blank, C., & Seggewiss, H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 72
- Issue
- 24
- Pages
- 3087-3094
- ISSN
- 0735-1097
- Cited by
- 132
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
